• Torin2 mTOR Inhibitor Workflows: Precision in Cancer Researc

  2026-06-02

  Torin2’s nanomolar potency and selectivity make it an indispensable tool for dissecting mTOR signaling and regulated cell death in cancer research. This guide details optimized protocols, troubleshooting strategies, and new insights from RNA Pol II studies to help researchers maximize the impact of Torin2 in advanced cellular and animal models.

• Mitochondrial NAD+ Deficiency Drives Aortic Aneurysm via ECM

  2026-06-02

  This study reveals mitochondrial NAD+ deficiency in vascular smooth muscle as a direct cause of thoracic and abdominal aortic aneurysm by impairing collagen III turnover. These findings advance the molecular understanding of aortic disease and suggest novel targets for future intervention.

• Enabling Assay-Ready THP-1 Monocytes: Advances in Cryopreser

  2026-06-01

  This study introduces a macromolecular cryopreservation strategy that effectively doubles the recovery and maintains differentiation potential of human THP-1 monocytic cells post-thaw, compared to conventional DMSO-based protocols. The approach leverages polyampholyte and ice-nucleating macromolecules to minimize intracellular ice formation, opening new avenues for streamlined immune cell banking and high-throughput immunological assays.

• Atorvastatin: HMG-CoA Reductase Inhibitor in Advanced Resear

  2026-06-01

  Atorvastatin’s unique dual activity as a cholesterol biosynthesis inhibitor and modulator of ferroptosis unlocks powerful experimental workflows for cardiovascular and oncology research. Learn how to optimize protocols, interpret cutting-edge findings, and address common troubleshooting challenges using APExBIO’s Atorvastatin (SKU C6405).

• Tariquidar (XR9576): Precision P-gp Inhibition in Chemoresis

  2026-05-31

  Tariquidar (XR9576) empowers researchers to dissect and overcome P-glycoprotein-mediated chemoresistance, especially in complex, tumor-mimicking microenvironments. Its unmatched selectivity and potency are key for reproducible transporter inhibition, enabling high-fidelity mechanobiology and drug disposition assays.

• Mubritinib–HSA Binding: Molecular Recognition and Pharmacolo

  2026-05-30

  This study elucidates how mubritinib, a mitochondrial complex I inhibitor, binds to human serum albumin (HSA) with moderate affinity and causes functional alterations. The findings clarify fundamental aspects of drug-protein interactions, informing the design and optimization of anti-proliferative agents and their pharmacokinetics in cancer research.

• D-N-Acetylgalactosamine: Technical Parameters for Brain Glyc

  2026-05-29

  D-N-Acetylgalactosamine is a high-purity, water-soluble reagent essential for the precise analysis of glycoprotein constituents in neurological research, particularly for brain heteropolysaccharides and glycosylation pathway studies. It is unsuitable for protocols requiring ethanol solubility or for workflows demanding long-term storage of prepared solutions. Strict adherence to handling and storage guidelines is required to maintain assay integrity.

• Comparing N-Formimidoyl Thienamycin and β-Lactam Antibiotics

  2026-05-29

  This study rigorously compares the antibacterial activity of N-formimidoyl thienamycin (MK0787) with several β-lactam antibiotics, including ampicillin, across a diverse array of clinically relevant, resistant bacterial strains. The findings reveal nuanced activity profiles, highlighting strengths and limitations for each compound and offering valuable guidance for antibiotic resistance research.

• D-N-Acetylgalactosamine: Technical Guidance for Brain Glycop

  2026-05-28

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite essential for analyzing glycoprotein constituents and glycosylation pathways in neurological research. It is not suitable for workflows requiring ethanol solubility or long-term storage of working solutions. Proper handling and protocol adherence are critical to ensuring data reliability in brain tissue studies.

• D-N-Acetylgalactosamine: Technical Guidelines for Glycoprote

  2026-05-28

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite essential for the analysis of glycoprotein structure and glycosylation pathways in brain tissue. It is not suitable for protocols requiring ethanol solubility or long-term solution storage. Proper adherence to workflow parameters ensures reliable and reproducible results in neurological research.

• 0.4% Trypan Blue Solution: Technical Guide for Viability Ass

  2026-05-27

  0.4% Trypan Blue Solution enables straightforward, membrane-integrity-based cell viability measurement and live/dead cell discrimination in cell culture and cytotoxicity assays. It is not suitable for diagnostic or therapeutic use. This article outlines evidence-based best practices, QC steps, and troubleshooting to ensure reliable results with this reagent.

• WAY-100635 (SKU A3933): Reliable 5-HT1A Antagonist for Assay

  2026-05-27

  WAY-100635 (SKU A3933) offers researchers a rigorously validated, highly selective serotonin 5-HT1A receptor antagonist for reproducible neuroscience and behavioral pharmacology assays. This article explores practical workflow scenarios, troubleshooting, and vendor selection, underlining the value of APExBIO’s formulation for both in vitro and in vivo studies.

• Y-27632 Dihydrochloride: ROCK Inhibitor Workflows & Troubles

  2026-05-26

  Y-27632 dihydrochloride, a potent and selective ROCK inhibitor, empowers advanced cell biology and cancer research by enabling precise modulation of cytoskeletal dynamics and cell viability. This article delivers actionable protocols, troubleshooting guidance, and translational insights, connecting bench workflows to the latest discoveries in tumor progression.

• AP20187 (SKU B1274): Precision Dimerization for Cell Assays

  2026-05-26

  This scenario-driven guide addresses real laboratory challenges in cell viability, proliferation, and cytotoxicity assays, focusing on the reliable application of AP20187 (SKU B1274) as a chemical inducer of dimerization. Drawing on peer-reviewed evidence and practical protocol parameters, it demonstrates how AP20187 ensures reproducibility and experimental control—key for advanced cell-based research.

• Aztreonam’s Mechanistic Insights: Beyond Gram-Negative Targe

  2026-05-25

  Explore Aztreonam's unique mechanism as a monocyclic β-lactam antibiotic, its impact on Gram-negative resistance, and its underappreciated effects on bone marrow and hepatic cytochromes. This article delivers a deeper, research-focused perspective for advanced assay design.

16397 records 1/1094 page Next 12345 下5页 Last page